Basics Kiniksa Pharmaceuticals, Ltd. IPO Date: May 21, 2018 Sector: Healthcare Industry: Biotech Market Cap: $2.05B Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 2.74% Avg Daily Range (30 D): $0.50 | 1.75% Avg Daily Range (90 D): $0.49 | 1.93% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): .54M Avg Daily Volume (90 D): .52M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 50 Institutional Trades Total Inst.Trades: 1,419 Avg Inst. Trade: $1.69M Avg Inst. Trade (30 D): $4.47M Avg Inst. Trade (90 D): $2.98M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.67M Avg Closing Trade (30 D): $6.21M Avg Closing Trade (90 D): $3.25M Avg Closing Volume: 87.84K     News Jun 5, 2025 @ 11:00 AM Kiniksa Pharmaceuticals Announces Trial Design of ... Source: N/A May 29, 2025 @ 8:01 PM Kiniksa Pharmaceuticals to Present at Upcoming Inv... Source: N/A Mar 14, 2025 @ 9:51 AM 3 No-Brainer Healthcare Stocks to Buy With $1,000 ... Source: Keith Speights Feb 20, 2025 @ 9:01 PM Kiniksa Pharmaceuticals to Report Fourth Quarter a... Source: N/A Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.24 $.12 $-.12 Diluted EPS $-.25 $.11 $-.12 Revenue $ 481.17M $ 137.79M $ 122.54M Gross Profit $ 412.97M $ 119.92M $ 104.64M Net Income / Loss $ -16.95M $ 8.54M $ -8.89M Operating Income / Loss $ -15.8M $ 13.27M $ -19.3M Cost of Revenue $ 68.2M $ 17.87M $ 17.9M Net Cash Flow $ 16.05M $ -26.45M $ 86.21M PE Ratio